Recombinant E. coli LLO/OVA vaccination effectively inhibits murine melanoma metastasis to lung by CD8+T cells immunity

Chinese Journal of Cancer Research

Volumn 21, Issue 1, 2009, Pages 44-49

  Xu, Man ^a   Dai, Ming Shen ^b   Mi, Can ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cytotoxic T cells; Metastasis; Recombinant E. coli; Tumorimmunity

Indexed keywords

ANAZOLENE SODIUM; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; LISTERIOLYSIN O; MELANOMA VACCINE; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CD3+ CD4+ T LYMPHOCYTE; CD3+ CD8+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; LUNG METASTASIS; LYMPHOCYTE SUBPOPULATION; MELANOMA B16; METASTASIS INHIBITION; MONOTHERAPY; MOUSE; NONHUMAN; STAINING; T CELL DEPLETION; WESTERN BLOTTING;

EID: 60349108867     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-009-0044-5     Document Type: Article

References (16)

1. Toso JF, Gill VJ, Hwu P, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma [J]. J Clin Oncol 2002;20:142-152.
2. Gunn GR, Zubair A, Peters C, et al. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16 [J]. J Immunol 2001;167:6471-6479.
3. Shahabi V, Reyes-Reyes M, Wallecha A, et al. Development of a Listeria monocytogenes based vaccine against prostate cancer [J]. Cancer Immunol Immunother 2008;57:1301-1313.
4. Vassaux G, Nitcheu J, Jezzard S, et al. Bacterial gene therapy strategies [J]. J Pathol 2006;208:290-298.
5. Critchley-Thorne RJ, Stagg AJ, Vassaux G. Recombinant Escherichia coli expressing invasin targets the Peyer's patches: The basis for a bacterial formulation for oral vaccination [J]. Mol Ther 2006;14:183-191.
6. Radford KJ, Higgins DE, Pasquini S, et al. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: Application to cancer immunotherapy [J]. Gene Ther 2002;9: 1445-1463.
7. Peng X, Hussain SF, Paterson Y The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function [J]. J Immunol 2004; 172:6030-6038.
8. Hu PQ, Tuma-Warrino RJ, Bryan MA, et al. Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8 + T cells following uptake by human APC [J]. J Immunol 2004;172:1595-1601.
9. Huleatt JW, Jacobs AR, Tang J, et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity [J]. Vaccine 2007;25:763-775.
10. Mandal M, Lee KD. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: Enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection [J]. Biochem Biophys Acta 2002;1563:7-17
11. Neeson P, Pan ZK, Paterson Y. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma [J]. Cancer Immunol Immunother 2008;57:493-505.
12. Tishler M, Shoenfeld Y. BCG immunotherapy-from pathophysiology to clinical practice [J]. Expert Opin Drug Saf 2006;5:225-229.
13. Panthel K, Meinel KM, Sevil Domènech VE, et al. Salmonella type III-mediated heterologous antigen delivery: A versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors [J]. Int J Med Microbiol 2008;298:99-103.
14. Shilling DA, Smith MJ, Tyther R, et al. Salmonella typhimurium stimulation combined with tumour-derived heat shock proteins induces potent dendritic cell anti-tumour responses in a murine model [J]. Clin Exp Immunol 2007;149:109-116.
15. Singh R, Paterson Y. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy [J]. Expert Rev Vaccines 2006;5:541-552
16. Xu Man, Mi Can. Effective activation of CD11c and anti-tumor immune by immunizing mice with recombinant E. coli LLO/OVA [J]. Acta Academiae Medicinae Militaris Tertiae (in Chinese) 2007; 29: 1702-1705.